JoVE Logo

Zaloguj się

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.

In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative deamination can occur, resulting in the formation of simpler amines, such as amphetamine.

Additional transformations can also occur, such as N-oxide formation in basic nitrogen atoms and N-hydroxylation in non-basic nitrogen atoms or those lacking an α-hydrogen.

Carbon-sulfur systems can undergo processes like S-dealkylation, S-alkylation, desulphurization, and S-oxidation. Sulphonamides and thiols, commonly found in various drugs, typically undergo these reactions. In contrast, carbon-oxygen systems predominantly undergo O-dealkylation. A classic example of a drug undergoing this type of reaction is codeine.

In addition to these specific reactions, there are also miscellaneous oxidative reactions. For example, reductive dehalogenation can occur in fluorocarbons like halothane, and the reduction of sulfur-containing groups can be seen in drugs like disulfiram. Understanding these complex biochemical reactions is critical in the pharmaceutical industry. Researchers and healthcare professionals can design and administer safer and more effective therapies by understanding how different compounds interact with the body's metabolic processes.

Tagi

Phase I ReactionsOxidative ReactionsCarbon heteroatom SystemsCarbon nitrogen SystemsAliphatic AminesN dealkylationOxidative DeaminationCarbon sulfur SystemsS oxidationSulphonamidesO dealkylationCodeineMiscellaneous Oxidative ReactionsReductive DehalogenationPharmaceutical Industry

Z rozdziału 5:

article

Now Playing

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

51 Wyświetleń

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

228 Wyświetleń

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

216 Wyświetleń

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

125 Wyświetleń

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

166 Wyświetleń

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

55 Wyświetleń

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

131 Wyświetleń

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

194 Wyświetleń

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

141 Wyświetleń

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

121 Wyświetleń

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

146 Wyświetleń

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

104 Wyświetleń

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

33 Wyświetleń

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

138 Wyświetleń

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

88 Wyświetleń

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone